valsartan has been researched along with azilsartan in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Giridhar, R; Murumkar, P; Naik, P; Yadav, MR | 1 |
| Bischoff-Kont, I; Fürst, R; Heering, J; Hernandez-Olmos, V; Kaps, A; Liu, T; Proschak, E; Rajkumar, R; Steinhilber, D | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bakris, GL; Cao, C; Handley, A; Kupfer, S; Perez, A; Sica, D; Weber, MA; White, WB | 1 |
| Ruilope, LM; Sierra, C | 1 |
| Hung, CS; Li-Ching, H; Miin-Jye, W; Shing, KK | 1 |
| Asayama, K; Haga, T; Hosaka, M; Imai, Y; Inoue, R; Kikuya, M; Mano, N; Metoki, H; Murakami, T; Obara, T; Ohkubo, T; Satoh, M | 1 |
| Fukushima, H; Horio, T; Ishimitsu, T; Iwashima, Y; Rai, T | 1 |
1 review(s) available for valsartan and azilsartan
| Article | Year |
|---|---|
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan | 2010 |
1 trial(s) available for valsartan and azilsartan
| Article | Year |
|---|---|
Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring.
Topics: Age Factors; Aged; Antihypertensive Agents; Benzimidazoles; Biological Availability; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension; Male; Middle Aged; Oxadiazoles; Sex Factors; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2011 |
6 other study(ies) available for valsartan and azilsartan
| Article | Year |
|---|---|
Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening.
Topics: | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Effectiveness of antihypertensive treatment and control of blood pressure: is it improvable?].
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Oxadiazoles; Tetrazoles; Valsartan | 2013 |
Noninferiority studies with multiple reference treatments.
Topics: Benzimidazoles; Blood Pressure; Equivalence Trials as Topic; Humans; Hypertension; Imidazoles; Oxadiazoles; Reference Standards; Research Design; Sample Size; Tetrazoles; Treatment Outcome; Valsartan | 2017 |
The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Oxadiazoles; Self Care; Telmisartan; Tetrazoles; Time Factors; Valsartan | 2016 |
Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertension.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Hypertension; Male; Stroke Volume; Tetrazoles; Valsartan | 2023 |